Amgen Highlights Data To Be Presented At AHA 2019 Across Cardiovascular Portfolio Read more about Amgen Highlights Data To Be Presented At AHA 2019 Across Cardiovascular Portfolio
Amgen To Present At The 28th Annual Credit Suisse Healthcare Conference Read more about Amgen To Present At The 28th Annual Credit Suisse Healthcare Conference
Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China Read more about Amgen Enters Into Strategic Collaboration With BeiGene To Expand Oncology Presence In China
The Discovery Of Amgen's Novel Investigational KRAS(G12C) Inhibitor AMG 510 Published In Nature Read more about The Discovery Of Amgen's Novel Investigational KRAS(G12C) Inhibitor AMG 510 Published In Nature
Amgen Reports Third Quarter 2019 Financial Results Read more about Amgen Reports Third Quarter 2019 Financial Results
Amgen Announces Webcast of 2019 Third Quarter Financial Results Read more about Amgen Announces Webcast of 2019 Third Quarter Financial Results
Amgen To Make Repatha® (evolocumab) Available Exclusively At Its Lower List Price Option In 2020 Read more about Amgen To Make Repatha® (evolocumab) Available Exclusively At Its Lower List Price Option In 2020
Amgen Recommends Rejection Of 'Mini-Tender' Offer From TRC Capital Corporation Read more about Amgen Recommends Rejection Of 'Mini-Tender' Offer From TRC Capital Corporation
David Meline, Amgen's Chief Financial Officer, To Retire Read more about David Meline, Amgen's Chief Financial Officer, To Retire
Amgen Announces 2019 Fourth Quarter Dividend Read more about Amgen Announces 2019 Fourth Quarter Dividend
